Possible Benefit of Angiotensin II Receptor Blockers in COVID-19 Patients: A Case Series

INTRODUCTION: Dysfunction in the renin-angiotensin-aldosterone system (RAAS) has been observed in patients with coronavirus disease 2019 (COVID-19). It is presumed that the effect of reducing interleukin-6 (IL-6) levels by angiotensin II receptor blockers (ARBs) by RAAS modulation. We investigated c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Su Jin, Kim, Taehwa, Cho, Woo Hyun, Jeon, Doosoo, Lim, Seungjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265029/
https://www.ncbi.nlm.nih.gov/pubmed/34285712
http://dx.doi.org/10.1155/2021/9951540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265029/
https://www.ncbi.nlm.nih.gov/pubmed/34285712
http://dx.doi.org/10.1155/2021/9951540

Ejemplares similares